DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 7AZACITIDINE
02 1BORTEZOMIB
Reset all filters
01 1201537
02 1204949
03 1207234
04 1207475
05 1207518
06 1209540
07 1209622
08 1215905
Reset all filters
01 8No
Drug : AZACITIDINE
Dosage Form : POWDER; INTRAVENOUS, SUBCUTANEOUS
Application Number : 201537
Country : US
Patented : No
Drug : AZACITIDINE
Dosage Form : POWDER; INTRAVENOUS, SUBCUTANEOUS
Application Number : 207475
Country : US
Patented : No
Drug : AZACITIDINE
Dosage Form : POWDER; INTRAVENOUS, SUBCUTANEOUS
Application Number : 209540
Country : US
Patented : No
Drug : AZACITIDINE
Dosage Form : POWDER; INTRAVENOUS, SUBCUTANEOUS
Application Number : 215905
Country : US
Patented : No
Drug : BORTEZOMIB
Dosage Form : INJECTABLE; INTRAVENOUS, SUBCUTANEOUS
Application Number : 209622
Country : US
Patented : No
Drug : AZACITIDINE
Dosage Form : POWDER; INTRAVENOUS, SUBCUTANEOUS
Application Number : 207234
Country : US
Patented : No
Drug : AZACITIDINE
Dosage Form : POWDER; INTRAVENOUS, SUBCUTANEOUS
Application Number : 204949
Country : US
Patented : No
Drug : AZACITIDINE
Dosage Form : POWDER; INTRAVENOUS, SUBCUTANEOUS
Application Number : 207518
Country : US
Patented : No